Key result
Identifying antecedents of adherence and improving patient activation may help provide disease- and patient-specific pathways to reduce avoidable vision loss.
Identifying antecedents of adherence and improving patient activation may help provide disease- and patient-specific pathways to reduce avoidable vision loss.
Supports adherence focus in vision loss; leaves open diagnosis-specific interventions.
Adherence to medication treatment protocols and active participation by individuals in their medical care are important for all patients, but especially for those with chronic conditions such as vision loss. Adherence is crucial for decreasing avoidable vision loss. Failure to take medications as prescribed and keep scheduled appointments reduces treatment effectiveness, increases complications and results in poorer outcomes. Reasons for nonadherence vary by diagnosis and include not understanding the importance of adherence, low health literacy, lack of adequate self-efficacy, low level of activation and behavioral issues including depression. Patients may lack information about their condition and its prognosis, available treatment alternatives, and other essential information such as how to monitor their eye condition, what to do if vision deteriorates and how to get needed community-based help. Each of these factors impedes patients' ability to engage with their physician and participate in their own care. The ability of individuals with vision loss to actively and effectively manage their health care, ie, activation, has been understudied. When patients are involved with their own care, their care experience, and most importantly, their outcomes, are improved. Identifying antecedents of adherence may help provide disease- and patient-specific pathways to reduce avoidable vision loss.
No takes yet. Share an insight, caveat, or question.
Morse et al. (2020) conducted a review in Vision loss. Adherence to medication treatment protocols was evaluated. Identifying antecedents of adherence and improving patient activation may help provide disease- and patient-specific pathways to reduce avoidable vision loss.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: